Clinical Trial Update: Renoprotective Effects of Telbivudine in Chronic Hepatitis B [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial assessing renoprotective effects of telbivudine in chronic hepatitis B patients is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Diseases
• Hepatitis B

Drugs mentioned

• Telbivudine (telbivudine)

Snippet

Sponsor: The University of Hong Kong | Conditions: Hepatitis B, Chronic, Chronic Kidney Diseases | Phase 4 | Status: COMPLETED